Axelyf, Inc.
PrivateLast Round
Seed
Oct 7, 2026
Total Funding Raised
$4.1M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Axelyf, Inc. operates in Healthcare & Life Sciences and is based in Brookline, Massachusetts. Its latest recorded funding round was a Seed round in August 2025.
Axelyf, Inc. is a biotechnology company developing RNA therapeutics and next-generation lipid nanoparticle delivery systems for oncology and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axelyf, Inc. Comparables
Compare Axelyf, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hopewell Therapeutics | 88% | |
| NanoVation Therapeutics | 84% | |
| Mana.bio | 82% |
For institutional investors. Book with your work email.
Axelyf, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 7, 2026 | ||||
| Seed | Aug 19, 2025 | ||||
| Grant | Aug 1, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Axelyf, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Brunnur Ventures | Seed |
| Omega ehf | Seed |
| Silfurberg ehf | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 7, 2026
Raised $2.6M in a Seed round.
- Jan 23, 2026
Grew 27% QoQ, from 11 to 14 employees.
For institutional investors. Book with your work email.
Axelyf, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Axelyf, Inc.'s valuation, stock price, and market status.
Is Axelyf, Inc. a public or private company?
Axelyf, Inc. is a private company.
What is the current stock price of Axelyf, Inc.?
Axelyf, Inc. is a private company, so its shares have no public market price. Caplight tracks Axelyf, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Axelyf, Inc. worth (valuation)?
Valuation information for Axelyf, Inc. is not publicly available.
Can I buy Axelyf, Inc. stock?
Axelyf, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Axelyf, Inc.'s last funding round?
Axelyf, Inc.'s most recent funding round was Seed on October 7, 2026.
Who are the main investors in Axelyf, Inc.?
Key investors in Axelyf, Inc. include Brunnur Ventures.
Will Axelyf, Inc. IPO soon?
No public IPO plans have been announced for Axelyf, Inc..
How can I track Axelyf, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Axelyf, Inc.'s shares on secondary markets.